CR6674A - Tratamiento de enzimas para infeccion - Google Patents

Tratamiento de enzimas para infeccion

Info

Publication number
CR6674A
CR6674A CR6674A CR6674A CR6674A CR 6674 A CR6674 A CR 6674A CR 6674 A CR6674 A CR 6674A CR 6674 A CR6674 A CR 6674A CR 6674 A CR6674 A CR 6674A
Authority
CR
Costa Rica
Prior art keywords
enzymes
treatment
infection
infective
carbohydrates
Prior art date
Application number
CR6674A
Other languages
English (en)
Spanish (es)
Inventor
M Anderson David
Liu Lin
Hsiao Humg-Yu
W Fodge Douglas
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR6674(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of CR6674A publication Critical patent/CR6674A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CR6674A 1999-12-10 2002-06-07 Tratamiento de enzimas para infeccion CR6674A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
CR6674A true CR6674A (es) 2007-02-22

Family

ID=22617824

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6674A CR6674A (es) 1999-12-10 2002-06-07 Tratamiento de enzimas para infeccion

Country Status (31)

Country Link
US (2) US6780628B2 (en, 2012)
EP (1) EP1239872B1 (en, 2012)
JP (1) JP4871473B2 (en, 2012)
KR (1) KR100639746B1 (en, 2012)
CN (3) CN101327320A (en, 2012)
AR (2) AR026764A1 (en, 2012)
AT (1) ATE481981T1 (en, 2012)
AU (1) AU782831B2 (en, 2012)
BR (1) BRPI0016231B8 (en, 2012)
CA (1) CA2394856C (en, 2012)
CL (1) CL2008000057A1 (en, 2012)
CO (1) CO5280226A1 (en, 2012)
CR (1) CR6674A (en, 2012)
CZ (1) CZ304925B6 (en, 2012)
DE (1) DE60045010D1 (en, 2012)
DK (1) DK1239872T3 (en, 2012)
ES (1) ES2353371T3 (en, 2012)
HU (1) HU230301B1 (en, 2012)
IL (2) IL150048A0 (en, 2012)
IN (1) IN247731B (en, 2012)
MX (1) MX264033B (en, 2012)
MY (1) MY124714A (en, 2012)
NZ (1) NZ519404A (en, 2012)
PH (1) PH12000003381B1 (en, 2012)
PL (1) PL203054B1 (en, 2012)
PT (1) PT1239872E (en, 2012)
RU (1) RU2272419C2 (en, 2012)
SK (1) SK287956B6 (en, 2012)
TW (1) TWI255189B (en, 2012)
UA (1) UA78486C2 (en, 2012)
WO (1) WO2001041785A2 (en, 2012)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US20080274095A1 (en) * 2004-10-20 2008-11-06 Jane Homan Biocides
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
SI1973561T1 (sl) * 2005-12-15 2011-07-29 Chemgen Corp Encimi, ki zmanjĺ ujejo imunski stres
JP2009523462A (ja) * 2006-01-23 2009-06-25 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の食物摂取を減少し、そして体重を制御するための方法
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
WO2008066403A1 (en) 2006-11-28 2008-06-05 Dmitry Dmitrievich Genkin Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
EP2980100A1 (en) * 2007-06-08 2016-02-03 Australian Poultry CRC Pty Ltd Clostridial toxin netb
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
US8597927B2 (en) * 2007-12-20 2013-12-03 Danisco Us Inc. Enzymatic prevention and control of biofilm
ES2645062T3 (es) * 2008-02-08 2017-12-04 Prothera, Inc. Inhibición y tratamiento de biopelículas gastrointestinales
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
CN105925548A (zh) 2012-02-16 2016-09-07 伊莱利利公司 用于减少动物废物的环境影响的方法和组合物
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
US11701410B2 (en) 2015-05-22 2023-07-18 Cls Therapeutics Limited Extracellular DNA as a therapeutic target in neurodegeneration
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
KR20200122320A (ko) 2018-01-16 2020-10-27 씨엘에스 테라퓨틱스 리미티드 데옥시리보뉴클레아제 (dnase) 활성을 갖는 효소의 간 발현에 의한 질환의 치료
US20210011027A1 (en) * 2018-03-02 2021-01-14 Evonik Operations Gmbh In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
DK0531437T3 (da) 1990-05-29 1998-08-31 Chemgen Corp Hemicellulasetilskud med henblik på at forbedre energiudnyttelsen af hemicelluloseholdige levnedsmidler og dyrefoder
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
SG42865A1 (en) * 1991-07-24 1997-10-17 Enzacor Pty Ltd Therapeutic compositions and methods
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) * 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
CN1235636A (zh) * 1996-10-31 1999-11-17 诺沃挪第克公司 新型磷脂酶,及其生产和应用
SK5022001A3 (en) 1998-10-15 2001-09-11 Dsm Nv Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116028A1 (en) * 2001-02-20 2002-08-22 Wilson Greatbatch MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality

Also Published As

Publication number Publication date
CN101327320A (zh) 2008-12-24
AU782831B2 (en) 2005-09-01
DE60045010D1 (de) 2010-11-04
SK287956B6 (sk) 2012-07-03
MY124714A (en) 2006-06-30
PL203054B1 (pl) 2009-08-31
CA2394856A1 (en) 2001-06-14
ES2353371T3 (es) 2011-03-01
PH12000003381B1 (en) 2010-04-16
KR100639746B1 (ko) 2006-10-30
IL150048A0 (en) 2002-12-01
JP4871473B2 (ja) 2012-02-08
KR20020069204A (ko) 2002-08-29
NZ519404A (en) 2004-05-28
WO2001041785A2 (en) 2001-06-14
CN102172262B (zh) 2014-03-05
WO2001041785A3 (en) 2002-01-24
US7723091B2 (en) 2010-05-25
HUP0203402A2 (hu) 2003-02-28
CN1433319A (zh) 2003-07-30
PT1239872E (pt) 2010-12-03
AR089799A2 (es) 2014-09-17
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
MX264033B (es) 2009-01-22
SK8262002A3 (en) 2002-12-03
EP1239872B1 (en) 2010-09-22
CO5280226A1 (es) 2003-05-30
HU230301B1 (hu) 2015-12-28
US20020048576A1 (en) 2002-04-25
CN102172262A (zh) 2011-09-07
DK1239872T3 (da) 2010-10-25
BR0016231A (pt) 2003-06-24
TWI255189B (en) 2006-05-21
PL356175A1 (en) 2004-06-14
HUP0203402A3 (en) 2004-12-28
RU2272419C2 (ru) 2006-03-27
IN247731B (en, 2012) 2011-05-13
CZ20022007A3 (cs) 2002-11-13
US6780628B2 (en) 2004-08-24
EP1239872A2 (en) 2002-09-18
IN2002DE00585A (en, 2012) 2009-03-20
JP2003520207A (ja) 2003-07-02
AU2577601A (en) 2001-06-18
UA78486C2 (uk) 2007-04-10
MXPA02005735A (es) 2003-10-14
US20040223961A1 (en) 2004-11-11
IL150048A (en) 2016-09-29
ATE481981T1 (de) 2010-10-15
BRPI0016231B8 (pt) 2021-05-25
CL2008000057A1 (es) 2008-03-14
CZ304925B6 (cs) 2015-01-28
BRPI0016231B1 (pt) 2016-10-04

Similar Documents

Publication Publication Date Title
CR6674A (es) Tratamiento de enzimas para infeccion
NO20063105L (no) Anordning og fremgangsmate for administrering av terapeutiske midler
BRPI0411924A8 (pt) Métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
AR025757A1 (es) Metodo para aumentar la actividad en mascotas
AR025599A1 (es) Metodo para mejorar la piel y el pelaje de mascotas
DE60034865D1 (de) Alloferone - immunomodulierende Peptide
NO20023464L (no) Sammensetning for intestinal avlevering
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
DK1763339T3 (da) Orale antimikrobielle farmaceutiske præparater
TW200602068A (en) Antidiarrheal agent for livestock and poultry
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
AR013480A1 (es) 9a-azalidas como agentes antimicrobicos veterinarios
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
YU14700A (sh) UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA
GB2377638B (en) Treatment of infection in animals
RU2001105595A (ru) Ветеринарный препарат
DK1196439T3 (da) Forbindelser udvisende en antibiotikaaktivitet
JP2021143172A (ja) 細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止する薬剤。
ES2130069B1 (es) Preparacion farmaceutica con liberacion retardada del producto activo.
RU2002129937A (ru) Штамм бактерий bacillus subtilis, используемый для получения пробиотического препарата, предназначенного для профилактики и лечения желудочно-кишечных заболеваний сельскохозяйственных животных, птицы и рыбы
TH49215B (th) องค์ประกอบซึ่งประกอบรวมด้วยเอนไซม์สำหรับรักษาการติดเชื้อของทางเดินอาหาร
TH54151A (th) องค์ประกอบซึ่งประกอบรวมด้วยเอนไซม์สำหรับรักษาการติดเชื้อของทางเดินอาหาร
UA37648A (uk) Спосіб лікування респіраторних захворювань у телят
UA40749A (uk) Препарат для лікування затримки посліду і ендометритів у корів - "ендосан"
DE602004010353D1 (de) Aktiviebare bioaktive implantierbare medizinische Vorrichtung.